PharmiWeb.com - Global Pharma News & Resources
30-May-2019

A fast-growing Mid-Level (public stock listed USA) company selected DDi mIRT XPRESS

As protocols turn out to be more complex and Clinical Trials become more patient-centric, Clinical Trial Supply Management is going to be one of the decisive factors for the success of Clinical Trials strategy.

Most Companies need IRT systems that are flexible, quick to set up, site and supply manager-friendly, and highly dependable.

This led to one of a Mid-Level fast-growing public company to select for mIRT XPRESS which is the only NO-Build system in the market currently available. After considering several vendors, this sponsor selected DDi’s mIRT XPRESS because it enables Clinical Trial Supply teams in full control with Super-fast implementation, flexibility and more importantly the best COST point comparatively.

About DDi LLC:

DDi LLC is a Technology and Solutions provider for Clinical Development and Regulatory to Life Sciences, Biotech and Pharmaceutical Industries. The company was founded in 1996; to develop strategic technology solutions to life sciences and headquartered in the heart of the Princeton, NJ.
DDi LLC has facilities and staff located in the U.S. and Europe and offers Global expertise and advisory services to Pharmaceutical Companies, Biotech and Contract Research Organizations. For more information, visit www.ddismart.com

A fast-growing Mid-Level (public stock listed USA) company selected DDi mIRT XPRESS

Editor Details

Last Updated: 30-May-2019